Literature DB >> 413793

Beta lactamase resistance of newer cephalosporins and antimicrobial effectiveness against gram-negative bacilli.

W E Farrar, N M O'Dell.   

Abstract

Three newer cephalosporins (cefamandole, cefoxitin and cefazaflur) were investigated, in comparison with three older agents (cephalothin, cephaloridine and cefazolin) to determine their stability to beta-lactamases of gram-negative bacilli, and to correlate this with their antibacterial activity. Nine of the 17 bacterial strains employed produced broadspectrum beta-lactamases; the remaining eight produced cephalosporinases. The cephalosporins were highly active against bacteria producing broad-spectrum beta-lactamases; they were less active against organisms producing cephalosporinases. All of the cephalosporinase-producing strains were resistant to cephalothin anc cephaloridine. With the other cephalosporins the correlation between hydrolysis by cephalosporinases and resistance of the organisms was poor. Four to eight cephalosporinase-producing strains were resistant to cefoxitin, which was completely resistant to hydrolysis by the beta-lactamases. Cefozolin, cefamandole and cefazaflur inhibited several of these strains in spite of destruction by the beta-lactamase. Several cephalosporins need to be used in antimicrobial susceptibility testing of gram-negative bacilli.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 413793     DOI: 10.1007/bf01640785

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  17 in total

1.  An inocula replicating apparatus for routine testing of bacterial susceptibility to antibiotics.

Authors:  E STEERS; E L FOLTZ; B S GRAVES
Journal:  Antibiot Chemother (Northfield)       Date:  1959-05

2.  A new parenteral cephalosporin. SK&F 59962: in vitro and in vivo antibacterial activity and serum levels in experimental animals.

Authors:  P Actor; J V Uri; J R Guarini; I Zajac; L Phillips; C S Sachs; R M DeMarinis; J R Hoover; J A Weisbach
Journal:  J Antibiot (Tokyo)       Date:  1975-06       Impact factor: 2.649

3.  Susceptibility of anaerobes to cefoxitin and other cephalosporins.

Authors:  F P Tally; N V Jacobus; J G Bartlett; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1975-02       Impact factor: 5.191

4.  Relative inactivation by Staphylococcus aureus of eight cephalosporin antibiotics.

Authors:  I W Fong; E R Engelking; W M Kirby
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

5.  Antibacterial activity of selected beta-lactam and aminoglycoside antibiotics against cephalothin-resistant Enterobacteriaceae.

Authors:  R P Lewis; R D Meyer; L L Kraus
Journal:  Antimicrob Agents Chemother       Date:  1976-05       Impact factor: 5.191

6.  Diversity of beta-lactamase activity among clinical isolates of gram-negative bacilli.

Authors:  W E Farrar; J K Newsome
Journal:  Am J Clin Pathol       Date:  1976-04       Impact factor: 2.493

Review 7.  The beta-lactamases of gram-negative bacteria and their role in resistance to beta-lactam antibiotics.

Authors:  R B Sykes; M Matthew
Journal:  J Antimicrob Chemother       Date:  1976-06       Impact factor: 5.790

8.  In vitro studies of cefamandole.

Authors:  G P Bodey; S Weaver
Journal:  Antimicrob Agents Chemother       Date:  1976-03       Impact factor: 5.191

9.  Antistaphylococcal activity and beta-lactamase resistance of newer cephalosporins.

Authors:  W E Farrar; P K Gramling
Journal:  J Infect Dis       Date:  1976-06       Impact factor: 5.226

10.  Cefoxitin, a semisynthetic cephamycin antibiotic: resistance to beta-lactamase inactivation.

Authors:  H R Onishi; D R Daoust; S B Zimmerman; D Hendlin; E O Stapley
Journal:  Antimicrob Agents Chemother       Date:  1974-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.